• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Respiratory Syncytial Virus Hospitalizations Associated With Social Vulnerability by Census Tract: An Opportunity for Intervention?按普查区划分的与社会脆弱性相关的呼吸道合胞病毒住院情况:干预的契机?
Open Forum Infect Dis. 2024 Mar 29;11(5):ofae184. doi: 10.1093/ofid/ofae184. eCollection 2024 May.
2
Relationship between neighborhood census-tract level socioeconomic status and respiratory syncytial virus-associated hospitalizations in U.S. adults, 2015-2017.2015-2017 年美国成年人中社区普查区社会经济地位与呼吸道合胞病毒相关住院治疗的关系。
BMC Infect Dis. 2021 Mar 23;21(1):293. doi: 10.1186/s12879-021-05989-w.
3
Respiratory syncytial virus-associated hospitalizations among children: an Italian retrospective observational study.呼吸道合胞病毒相关儿童住院治疗:意大利回顾性观察研究。
Ital J Pediatr. 2024 Mar 7;50(1):45. doi: 10.1186/s13052-024-01617-w.
4
Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014-15.美国 2014-2015 年<2 岁儿童因呼吸道合胞病毒引起的社区获得性住院负担估计。
J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):587-595. doi: 10.1093/jpids/piz087.
5
Estimated Incidence of Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections Among Adults in Germany Between 2015 and 2019.2015年至2019年间德国成年人中因呼吸道合胞病毒感染导致的住院和死亡估计发病率。
Infect Dis Ther. 2024 Apr;13(4):845-860. doi: 10.1007/s40121-024-00951-0. Epub 2024 Mar 23.
6
Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children.基于人群的幼儿呼吸道合胞病毒、流感病毒和副流感病毒相关住院监测。
Pediatrics. 2004 Jun;113(6):1758-64. doi: 10.1542/peds.113.6.1758.
7
A Retrospective Cohort Study on Infant Respiratory Tract Infection Hospitalizations and Recurrent Wheeze and Asthma Risk: Impact of Respiratory Syncytial Virus.一项关于婴儿呼吸道感染住院和反复喘息及哮喘风险的回顾性队列研究:呼吸道合胞病毒的影响。
J Infect Dis. 2022 Aug 12;226(Suppl 1):S55-S62. doi: 10.1093/infdis/jiac141.
8
Estimates of the national burden of respiratory syncytial virus in Kenyan children aged under 5 years, 2010-2018.2010-2018 年肯尼亚 5 岁以下儿童呼吸道合胞病毒全国负担估计。
BMC Med. 2023 Mar 31;21(1):122. doi: 10.1186/s12916-023-02787-w.
9
Age-Specific Estimates of Respiratory Syncytial Virus-Associated Hospitalizations in 6 European Countries: A Time Series Analysis.6 个欧洲国家中与呼吸道合胞病毒相关的住院的年龄特异性估计:时间序列分析。
J Infect Dis. 2022 Aug 12;226(Suppl 1):S29-S37. doi: 10.1093/infdis/jiac150.
10
Incidence of Respiratory Syncytial Virus Infection in Older Adults Before and During the COVID-19 Pandemic.老年人在 COVID-19 大流行前后感染呼吸道合胞病毒的情况。
JAMA Netw Open. 2023 Jan 3;6(1):e2250634. doi: 10.1001/jamanetworkopen.2022.50634.

引用本文的文献

1
Evaluating the efficacy, safety, and immunogenicity of FDA-approved RSV vaccines: a systematic review of Arexvy, Abrysvo, and mResvia.评估美国食品药品监督管理局(FDA)批准的呼吸道合胞病毒(RSV)疫苗的疗效、安全性和免疫原性:对Arexvy、Abrysvo和mResvia的系统评价
Front Immunol. 2025 Aug 18;16:1624007. doi: 10.3389/fimmu.2025.1624007. eCollection 2025.
2
RSV: an overview of infection in adults.呼吸道合胞病毒:成人感染概述
Pneumonia (Nathan). 2025 Jun 25;17(1):15. doi: 10.1186/s41479-025-00165-z.
3
Socioeconomic Inequities in the Age-Specific Burden of Severe Respiratory Syncytial Virus in Canada, 2016-2019.2016 - 2019年加拿大特定年龄严重呼吸道合胞病毒负担中的社会经济不平等现象
J Infect Dis. 2025 Apr 15;231(4):e626-e637. doi: 10.1093/infdis/jiae635.

本文引用的文献

1
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.《妊娠期使用辉瑞呼吸道合胞病毒疫苗预防婴儿呼吸道合胞病毒相关下呼吸道疾病:免疫实践咨询委员会建议-美国,2023 年》。
MMWR Morb Mortal Wkly Rep. 2023 Oct 13;72(41):1115-1122. doi: 10.15585/mmwr.mm7241e1.
2
Respiratory Syncytial Virus-Associated Hospital Admissions by Deprivation Levels Among Children and Adults in Scotland.苏格兰儿童和成人中按贫困程度划分的呼吸道合胞病毒相关住院情况
J Infect Dis. 2024 Mar 1;229(Supplement_1):S61-S69. doi: 10.1093/infdis/jiad428.
3
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. Reply.孕期接种二价预融合F疫苗预防婴儿呼吸道合胞病毒疾病。回复。
N Engl J Med. 2023 Sep 14;389(11):1053-1055. doi: 10.1056/NEJMc2307729.
4
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.《使用尼赛珠单抗预防婴幼儿呼吸道合胞病毒疾病:免疫实践咨询委员会的建议-美国,2023 年》。
MMWR Morb Mortal Wkly Rep. 2023 Aug 25;72(34):920-925. doi: 10.15585/mmwr.mm7234a4.
5
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.《老年人使用呼吸道合胞病毒疫苗:免疫实践咨询委员会的建议——美国,2023 年》。
MMWR Morb Mortal Wkly Rep. 2023 Jul 21;72(29):793-801. doi: 10.15585/mmwr.mm7229a4.
6
RSV Among American Indian and Alaska Native Children: 2019 to 2020.2019年至2020年美国印第安人和阿拉斯加原住民儿童中的呼吸道合胞病毒感染情况
Pediatrics. 2023 Aug 1;152(2). doi: 10.1542/peds.2022-060435.
7
Seasonality in Respiratory Syncytial Virus Hospitalizations and Immunoprophylaxis.呼吸道合胞病毒住院治疗与免疫预防的季节性。
JAMA Health Forum. 2023 Jun 2;4(6):e231582. doi: 10.1001/jamahealthforum.2023.1582.
8
Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection.帕利珠单抗预防高风险住院的婴幼儿呼吸道合胞病毒感染。
Pediatrics. 2023 Jul 1;152(1). doi: 10.1542/peds.2023-061803.
9
Seasonality of Respiratory Syncytial Virus - United States, 2017-2023.呼吸道合胞病毒的季节性 - 美国,2017-2023 年。
MMWR Morb Mortal Wkly Rep. 2023 Apr 7;72(14):355-361. doi: 10.15585/mmwr.mm7214a1.
10
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.一种二价呼吸道合胞病毒预融合F疫苗在老年人中的疗效和安全性
N Engl J Med. 2023 Apr 20;388(16):1465-1477. doi: 10.1056/NEJMoa2213836. Epub 2023 Apr 5.

按普查区划分的与社会脆弱性相关的呼吸道合胞病毒住院情况:干预的契机?

Respiratory Syncytial Virus Hospitalizations Associated With Social Vulnerability by Census Tract: An Opportunity for Intervention?

作者信息

Thomas Christine M, Raman Rameela, Schaffner William, Markus Tiffanie M, Ndi Danielle, Fill Mary-Margaret A, Dunn John R, Talbot H Keipp

机构信息

Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Communicable and Environmental Diseases and Emergency Preparedness Division, Tennessee Department of Health, Nashville, Tennessee, USA.

出版信息

Open Forum Infect Dis. 2024 Mar 29;11(5):ofae184. doi: 10.1093/ofid/ofae184. eCollection 2024 May.

DOI:10.1093/ofid/ofae184
PMID:38680605
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11055400/
Abstract

BACKGROUND

Respiratory syncytial virus (RSV) can cause hospitalization in young children and older adults. With vaccines and monoclonal antibody prophylaxis increasingly available, identifying social factors associated with severe illnesses can guide mitigation efforts.

METHODS

Using data collected by the RSV Hospitalization Surveillance Network from 2016 to 2023, we identified RSV hospitalizations in Tennessee. We linked hospitalization information (eg, patient demographic characteristics and outcome) with population-level variables (eg, social vulnerability and health care insurance coverage) from publicly available data sets using census tract of residence. Hospitalization incidence was calculated and stratified by period (2016-2020 and 2020-2023). We modeled social vulnerability effect on hospitalization incidence using Poisson regression.

RESULTS

Among 2687 RSV hospitalizations, there were 677 (25.2%) intensive care unit admissions and 38 (1.4%) deaths. The highest RSV hospitalization incidences occurred among children aged <5 years and adults aged ≥65 years: 272.8 per 100 000 person-years (95% CI, 258.6-287.0) and 60.6 (95% CI, 56.0-65.2), respectively. Having public health insurance was associated with higher hospitalization incidence as compared with not having public insurance: 60.5 per 100 000 person-years (95% CI, 57.6-63.4) vs 14.3 (95% CI, 13.4-15.2). Higher hospitalization incidence was associated with residing in a census tract in the most socially vulnerable quartile vs the least vulnerable quartile after adjusting for age, sex, and period (incidence rate ratio, 1.4; 95% CI, 1.3-1.6).

CONCLUSIONS

RSV hospitalization was associated with living in more socially vulnerable census tracts. Population measures of social vulnerability might help guide mitigation strategies, including vaccine and monoclonal antibody promotion and provision to reduce RSV hospitalization.

摘要

背景

呼吸道合胞病毒(RSV)可导致幼儿和老年人住院。随着疫苗和单克隆抗体预防措施越来越容易获得,识别与严重疾病相关的社会因素可以指导缓解措施。

方法

利用RSV住院监测网络2016年至2023年收集的数据,我们确定了田纳西州的RSV住院病例。我们使用居住普查区将住院信息(如患者人口统计学特征和结局)与公开数据集中的人口水平变量(如社会脆弱性和医疗保险覆盖范围)相联系。计算住院发病率并按时间段(2016 - 2020年和2020 - 2023年)分层。我们使用泊松回归对社会脆弱性对住院发病率的影响进行建模。

结果

在2687例RSV住院病例中,有677例(25.2%)入住重症监护病房,38例(1.4%)死亡。RSV住院发病率最高的是年龄小于5岁的儿童和年龄≥65岁的成年人:分别为每10万人年272.8例(95%置信区间,258.6 - 287.0)和60.6例(95%置信区间,56.0 - 65.2)。与没有公共保险相比,拥有公共医疗保险与更高的住院发病率相关:每10万人年60.5例(95%置信区间,57.6 - 63.4)对14.3例(95%置信区间,13.4 - 15.2)。在调整年龄、性别和时间段后,居住在社会最脆弱四分位数普查区的住院发病率高于最不脆弱四分位数普查区(发病率比,1.4;95%置信区间,1.3 - 1.6)。

结论

RSV住院与居住在社会更脆弱的普查区有关。社会脆弱性的人口指标可能有助于指导缓解策略,包括推广和提供疫苗及单克隆抗体以减少RSV住院。